A genetic mutation in horses that would typically halt protein production has become a molecular asset. Researchers at Johns ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID ...

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

Their differences, which determine their effect on your health, are defined by each fat's chemical composition and the bonds between the fatty acid molecules. The fats you consume affect your levels ...